Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 3 , Pages 175-191 , September 2005

Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications

  • João Paulo Tardivo

      Affiliations

    • Faculdade de Medicina ABC, Av. Príncipe de Gales, 821, C.P. 106, CEP 09060-650, Brazil
    • ,
  • Auro Del Giglio

      Affiliations

    • Faculdade de Medicina ABC, Av. Príncipe de Gales, 821, C.P. 106, CEP 09060-650, Brazil
    • ,
  • Carla Santos de Oliveira

      Affiliations

    • Departamento de Bioquímica, IQ-USP, C.P. 26077, 05513-970 São Paulo, SP, Brazil
    • ,
  • Dino Santesso Gabrielli

      Affiliations

    • Departamento de Bioquímica, IQ-USP, C.P. 26077, 05513-970 São Paulo, SP, Brazil
    • ,
  • Helena Couto Junqueira

      Affiliations

    • Departamento de Bioquímica, IQ-USP, C.P. 26077, 05513-970 São Paulo, SP, Brazil
    • ,
  • Dayane Batista Tada

      Affiliations

    • Departamento de Bioquímica, IQ-USP, C.P. 26077, 05513-970 São Paulo, SP, Brazil
    • ,
  • Divinomar Severino

      Affiliations

    • Departamento de Bioquímica, IQ-USP, C.P. 26077, 05513-970 São Paulo, SP, Brazil
    • ,
  • Rozane de Fátima Turchiello

      Affiliations

    • Departamento de Bioquímica, IQ-USP, C.P. 26077, 05513-970 São Paulo, SP, Brazil
    • ,
  • Mauricio S. Baptista, PhD

      Affiliations

    • Departamento de Bioquímica, IQ-USP, C.P. 26077, 05513-970 São Paulo, SP, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55 11 30913815; fax: +55 11 38155579.

References 

  1. Dougherty TJ. Photochemistry in the treatment of cancer. Adv Photochem. 1992;17:275–311
  2. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol. 2000;42:389–413
  3. Brown SB, Brown EA, Walker I. The present and the future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5:497–508
  4. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumors. J Photochem Photobiol B. 1997;39:1–18
  5. Baptista MS, Indig GL. Effect of BSA binding on photophysical and photochemical properties of triarylmethane dyes. J Phys Chem B. 1998;102:4678–4688
  6. Foote CS. Mechanisms of photosensitized oxidation. Science; 162:963–70.
  7. Van Hillegersberg R, Hekking-Weijma JM, Wilson JH, Edixhoven-Bosdijk A, Kort WJ. Adjuvant intraoperative photodynamic therapy diminishes the rate of local recurrence in a rat mammary tumour model. Br J Cancer. 1995;71:733–777
  8. Haddad R, Kaplan O, Brazovski E, et al. Effect of photodynamic therapy on normal fibroblasts and colon anastomotic healing in mice. J Gastrintest Surg. 1999;3:602–606
  9. Tardivo JP, Del Giglio A, Paschoal LH, Ito AS, Baptista MS. Treatment of melanoma lesions using methylene blue and RL50 light source. Photodiagn Photodyn Ther. 2004;1:345–346
  10. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle DG, Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978;38:2628–2633
  11. Dougherty TJ. Photodynamic therapy. In:  Withers HR,  Peters LJ editor. Innovations in radiation oncology. Berlin/Heidelberg: Springer-Verlag; 1988;p. 175–188
  12. Via LD, Magno SM. Photochemotherapy in the treatment of cancer. Curr Med Chem. 2001;8:1405–1418
  13. Ellison RR, Downie GH, Cuenca R, Hu X-H, Childs CJH , Sibata CH. Photosensitizers in clinical PDT. Photodiagn Photodyn Ther. 2004;1:27–42
  14. Mang TS. Lasers and light sources for PDT: past, present and future. Photodiagn Photodyn Ther. 2004;1:43–48
  15. Ochsner M. Light scattering of human skin: a comparison between zinc(II)-phthalocyanine and Photofrin II. J Photochem Photobiol B. 1996;32:3–9
  16. Konig K, Bockhorn V, Dietel W, Schubert H. Photochemotherapy of animal tumors with photosensitizer methylene blue using a krypton laser. J Cancer Res Clin Oncol. 1987;113:301–303
  17. Orth K, Rück A, Beck G, Stanescu A, Beger HG. Photodynamische Therapie Kleiner Adenocarcinome mit Methylenblau. Chirurg. 1995;66:1254–1257
  18. Orth K, Russ D, Beck G, Ruck A, Berger HG. Photochemotherapy of experimental colonic tumours with intra-tumorally applied methylene blue. Langenbecks Arch Surg. 1998;383:276–281
  19. Tuite EM, Kelly JM. Photochemical interactions of methylene blue and analogues with DNA and other biological substrates. J Photochem Photobiol B. 1993;21:103–124
  20. Junqueira HC, Severino D, Dias LG, Gugliotti M, Baptista MS. Modulation of the methylene blue photochemical properties based on the adsorption at aqueous micelle interfaces. Phys Chem Chem Phys. 2002;4:2320–2328
  21. Severino D, Junqueira HC, Gabrielli DS, Gugliotti M, Baptista MS. Influence of negatively charged interfaces on the ground and excited state properties of methylene blue. Photochem Photobiol. 2003;77:459–468
  22. Bonneau R, Pottier R, Bagno O, Joussot-Dubien J. pH dependence of singlet oxygen production in aqueous solutions using thiazine dyes as photosensitizers. Photochem Photobiol. 1975;21:159–253
  23. Voet D, Voet J. Biochemistry. 2nd ed.. New York: Wiley; 1995;
  24. Baptista MS. Supramolecular assemblies of natural and synthetic polyelectrolytes. In:  Tripathy SK,  Kumar J,  Nalwa HS editor. Handbook of polyelectrolytes and their applications. vol. 1:American Scientific Publishers; 2002;p. 165–181
  25. Morgan J, Whitaker JE, Oseroff AR. GRP78 induction by calcium ionophore potentiates photodynamic therapy using the mitochondrial targeting dye Victoria Blue BO. Photochem Photobiol. 1998;67:155–164
  26. Kandela IK, Lee W, Indig GL. Effect of the lipophilic/hydrophilic character of cationic triarylmethane dyes on their selective phototoxicity toward tumor cells. Biotechnic Histochem. 2003;78:157–169
  27. Link EM. Targeting melanoma with 211At/131 I—methylene blue: preclinical and clinical experience. Hybridoma. 1999;18:77–82
  28. Rice L, Wainwright M, Phoemix DA. Phenothiazine photosensitizers III. Activity of methylene blue derivates against pigmented melanoma cell lines. J Chemother. 2000;12:94–104
  29. Link EM, Blower PJ, Costa DC, et al. Early detection of melanoma metastases with radioiodinated methylene blue. Eur J Nucl Med. 1998;25:1322–1329
  30. Link EM, Michalowski AS, Rosch F. At-211-methylene blue for targeted radiotherapy of disseminated melanoma: Microscopic analysis of tumour versus normal tissue damage. Eur J Cancer. 1996;32A:1986–1994
  31. Dubois D, Lederman JA, Link EM, Stauss H, Collins M. Malignant-melanoma. Lancet. 1992;340:948–991
  32. Link EM, Brown I, Carpenter RN, Mitchell JS. Uptake and therapeutic effectiveness of i-125 methylene and at-211 methylene blue for pigmented melanoma in an animal-model system. Cancer Res. 1989;49:4332–4337
  33. Baker A, Kanofsky JR. Quenching of singlet oxygen by biomolecules from L1210 leukemia cells. Photochem Photobiol. 1992;55:523–528
  34. Valenzeno DP. Modification of biological membranes with emphasis on singlet oxygen mechanisms. Photochem Photobiol. 1987;46:147–160
  35. Bellnier DA, Dougherty TJ. Membrane lysis in chinese-hamster ovary cells treated with hematoporphyrin derivative plus light. Photochem Photobiol. 1982;36:43–47
  36. Robinson JR. Photodynamic insecticides—a review of studies on photosensitizing dyes as insect control agents, their practical application, hazards, and residues. Residue Rev. 1983;88:69–100
  37. Ito T, Kobayashi K. Survey of in vivo photodynamic activity of xanthenes, thiazines, and acridines in yeast-cells. Photochem Photobiol. 1977;26:581–587
  38. Kaplan JC, Chirouze M. Therapy of recessive congenital methemoglobinemia by oral riboflavine. Lancet. 1978;1043–1044
  39. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999;34:646–656
  40. Takeoka S, Ohgushi T, Nishide H, Tsuchida E. Reduction of methemoglobin via electron transfer across the bilayer membrane of Hb vesicles. Bull Chem Soc Jpn. 1997;70:1171–1178
  41. Zanocco AL, Gunther G, Lemp E, Lissi EA. Release of methylene blue from dioctadecyldimethylammonium chloride vecicles. J Chem Soc, Perkin Trans. 1998;2:319–323
  42. Gross E, Ehrenberg B, Johnson FM. Singlet oxygen generation by porphyrins and the kinetics of 9,10-dimethylanthracene photosensitization in liposomes. Photochem Photobiol. 1993;57:808–813
  43. Lee PC, Rodgers MAJ. Singlet molecular-oxygen in micellar systems.1. Distribution equilibria between hydrophobic and hydrophilic compartments. J Phys Chem. 1983;87:4894–4898
  44. Lamola AA, Yamane T, Trozzolo AM. Cholesterol hydroperoxide formation in red-cell membranes and photohemolysis in erythropoietic protoporphyria. Science. 1973;179:1131–1133
  45. Doleiden FH, Fahrenholtz SR, Lamola AA, Trozzolo AM. Reactivity of cholesterol and some fatty-acids toward singlet oxygen. Photochem Photobiol. 1974;20:519–521
  46. Vever-Bizet C, Dellinger M, Brault D, Rougee M, Bensasson RV. Singlet molecular oxygen quenching by saturated and unsaturated fatty-acids and by cholesterol. Photochem Photobiol. 1989;50:321–325
  47. Girotti AW. Photodynamic lipid peroxidation in biological systems. Photochem Photobiol. 1990;51:497–509
  48. Muller-Runkel R, Blais J, Grossweiner LI. Photodynamic damage to egg lecithin liposomes. Photochem Photobiol. 1981;33:683–687
  49. Grossweiner LI, Grosseweiner JB. Hydrodynamic effect on the photosensitized lysis of liposomes. Photochem Photobiol. 1982;35:583–586
  50. Bunting JR. A test of the singlet oxygen mechanism of cationic dye photosensitization of mitochondrial damage. Photochem Photobiol. 1992;55:81–87
  51. Kessel D, Luo Y. Mitochondrial photodamage and PDT-induced apoptosis. J Photochem Photobiol B: Biol. 1998;42:89–95
  52. Kandela IK, Bartlett JA, Indig GL. Effect of molecular structure on the selective phototoxicity of triarylmethane dyes towards tumor cells. Photochem Photobiol Sci. 2002;1:309–314
  53. Kowaltowski AJ, Turin J, Indig GL, Vercesi AE. Mitochondrial effects of triarylmethane dyes. J Bioenerg Biomembr. 1999;31:581–590
  54. Rugolo M, Lenaz G. Monitoring of the mitochondrial and plasma membrane potentials in human fibroblasts by tetraphenylphosphonium ion distribution. J Bioenerg Biomembr. 1987;19:705–718
  55. Gabrieli D, Belisle E, Severino D, Kowaltowski AJ, Baptista MS. Methylene blue aggregation in liver mouse mitochondria. Photochem Photobiol. 2004;79:227–232
  56. Petrat F, Pindiur S, Kirsch M, Groot H. NAD(P)H, a primary target of 1O2 in mitochondria of intact cells. J Biol Chem. 2003;278:3298–3307
  57. Petrat F, Pindiur S, Kirsch M, Groot H. “Mitochondrial” photochemical drugs do not release toxic amounts of 1O2 within the mitochondrial matrix space. Arch Biochem Biophys. 2003;412:207–215
  58. Knowles A, Gurnani S. Methylene blue sensitized photoinactivation of E. coli ribosomes: effect on the RNA and protein components. Photochem Photobiol. 1972;16:117–124
  59. Santus R, Kohen C, Kohen E, et al. Permeation of lysosomal membranes in the course of photosensitization with methylene blue and hematoporphyrin: study by cellular microspectrofluorometry. Photochem Photobiol. 1983;38:71–77
  60. Rashid F, Horobin RW. Interaction of molecular probes with living cells and tissues. 2. A structure-activity analysis of mitochondrial staining by cationic probes, and a discussion of the synergistic nature of image-based and biochemical approaches. Histochemistry. 1990;94:303–308
  61. Rück A, Köllner T, Kietrich A, Strauss W, Schneckenburger H. Fluorescence formation during photodynamic therapy in the nucleus of cells incubated with cationic and anionic water-soluble photosensitizers. J Photochem Photobiol B: Biol. 1992;12:403–412
  62. Yu DS, Chang SY, Ma CP. The effect of methylene blue-sensitized photodynamic treatment on bladder-cancer cells—a further study on flow cytometric basis. J Urol. 1993;149:1198–1204
  63. Gutter B, Nishioka Y, Speck WT, Rosenkranz HS, Lubit B, Erlanger BF. Immunofluorescence for the detection of photochemical lesions in intracellular DNA. Exptl Cell Res. 1976;102:413–416
  64. Ball DJ, Luo Y, Kessel D, Griffiths J, Brown SB, Vernon DI. The induction of apoptosis by a positively charged methylene blue derivative. J Photochem Photobiol B: Biol. 1998;42:159–163
  65. Wainwright M, Phoenix DA, Rice L, Burrow SM, Waring J. Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation. J Photochem Photobiol B: Biol. 1997;40:233–239
  66. Schick E, Kaufamann R, Rück A, Hainzl A, Boehncke H. Influence of activation and differentiation of cell on the effectiveness of photodynamic therapy. Acta Derm Venereol. 1995;75:276–279
  67. Trindade GS, Farias SLA, Rumjanek VM, Capella MAM. Methylene blue reverts multidrug resistance: sensivity of multidrug resistant cells to this dye and its photodynamic action. Cancer Lett. 2000;151:161–167
  68. Lee YS, Wurster RD. Methylene blue induces cytotoxicity in human brain tumor cells. Cancer Lett. 1995;88:141–145
  69. Boehncke WH, Ruck A, Naumann J, Sterry W, Kaufmann R. Comparison of sensitivity towards photodynamic therapy of cutaneous resident and infiltrating cell types in vitro. Lasers Surg Med. 1996;19:451–457
  70. Capella MAM, Capella LS. A light in multidrug resistance: photodynamic treatment of multidrug-resistance tumors. J Biomed Sci. 2003;10:361–366
  71. Mellish K, Cox RD, Vernon DI, Griffiths J, Brown SB. In vitro photodynamic activity of a series of methylene blue analogues. Photochem Photobiol. 2002;75:392–397
  72. Plaetzer K, Kiesslich T, Oberdanner CB, Krammer B. Apoptosis following photodynamic thumor therapy: induction, mechanisms and detection. Curr Pharm Des. 2005;11:1151–1165
  73. Lemasters JJ. Dying a thousand deaths: redundant pathways from different organelles to apoptosis and necrosis. Gastroenterology. 2005;129:351–360
  74. Kochevar IE, Lynch , Zhyang SG, Lambert CR. Singlet oxygen, but not oxidizing radicals, induces apoptosis in HL-60 cells. Photochem Photobiol. 2000;72:548–553
  75. Jori G, Fabris C. Relative apoptosis and random necrosis in tumor response to photodynamic therapy: effect of the chemical structure of Zn-phtalocyanines. J Photochem Photobiol B: Biol. 2000;43:181–185
  76. Almeida RD, Manadas BJ, Carvalho AP, Duarte CB. Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta. 2004;1704:59–86
  77. Kessel D, Luo D, Deng Y, Chang CK. The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem Photobiol. 1997;65:422–426
  78. Lam M, Oleinick NL, Nieminen AL. Photodynamic therapy-induced apoptosis in epidermoid carcinoma cells. Reactive oxygen species and mitochondrial inner membrane permebialization. J Biol Chem. 2001;276:47379–47386
  79. Zhelev Z, Ohba H, Bakalova R, et al. Phenotiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Cancer Chemother Pharmacol. 2004;53:267–275
  80. Estevam ML, Nascimento OR, Baptista MS, et al. Changes in the spin state and reactivity of cytochrome c induced by photochemicaly generated singlet oxygen and free radicals. J Biol Chem. 2004;279:39214–39222
  81. Noodt BB, Rodal GH, Waiwright M, et al. Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells. Int J Cancer. 1998;75:941–948
  82. Spector DL, Goldman RD, Leinwand LA. Cells: a laboratory manual, vol. 1: culture and biochemical analysis of cells. Spring Harbor laboratory press; 1998;[cap. 15]
  83. (a)Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). Rev J Antimicrob Chemother. 1998;42:13–28(b)Wainwright M. Photochem Photobiol Sci. 2004;5:406–411
  84. Lambrechts SAG, Demidova TN, Aalders MCG, Hasan T, Hablin MR. Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci. 2005;4:503–509
  85. Schultz EW, Krueger AP. Inactivation of Staphylococcus bacteriophage by methylene blue. Proc Soc Exp Biol Med. 1930;26:100–101
  86. Wakayama Y, Takagi M, Yano K. Photosensitized inactivation of E. coli cells in toluidine blue system. Photochem Photobiol. 1980;32:601–605
  87. Boehncke W-H, Rück A, Naumann J, Sterry W, Kaufmann R. Comparison of sensitivity towards photodynamic therapy of cutaneous resident an infiltrating cell types in vitro. Lasers Surg Med. 1996;19:451–457
  88. Lee D, Foux M, Leonard EF. The effects of methylene blue and oxygen concentration on the photoinactivation of Q beta bacteriophage. Photochem Photobiol. 1997;65:161–165
  89. Wagner SJ, Skripchencko A, Robinette D, Foley JW, Cincotta L. Factors affecting virus photoinactivation by a series of phenothiazine dyes. Photochem Photobiol. 1998;67:343–349
  90. Bockstaheler LE, Coohill TP, Hellman KB, Lytle CD, Roberts JE. Photodynamic therapy for herpes simplex: a critical review. Pharmacol Ther. 1979;4:473–499
  91. Müller-Breitkreutz K, Mohr H. Infection cycle of herpes viruses after photodynamic treatment with methylene blue and light. Beitr Infusionsther Transfusionsmed. 1997;34:37–42
  92. Fisher AMR, Murphree AL, Gomer CJ. Clinical and preclinical photodynamic therapy. Lasers Surg Med. 1995;17:2–31
  93. Lambrecht B, Mohr H, KnIuver-Hopf J, Schmitt H. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sang. 1991;60(4):207–213
  94. Bachmann B, Knüver-Hopf J, Lambrecht B, Mohr H. Target structures for HIV-1 inactivation by methylene blue and light. J Med Virol. 1995;47(2):172–178
  95. Boehncke W-H, Rück A, Naumann J, Sterry W, Kaufmann R. Comparison of sensitivity towards photodynamic therapy of cutaneous resident an infiltrating cell types in vitro. Lasers Surg Med. 1996;19:451–457
  96. Wainwright M, Phoenix DA, Laycock SL, Wareing DR, Wright PA. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett. 1998;160:177–181
  97. Wainwright M, Phoenix DA, Gaskell M, Marshall B. Photobactericidal activity of methylene blue derivates against vancomycin-resistant Enterococcus spp. J Antimicrob Chemother. 1999;44(6):823–825
  98. Demidova TN, Hamblin MR. Photodynamic therapy targeted to pathogens. Int J Immun Pharmacol. 2004;17:245–254
  99. Bellin JS, Lutwick L, Jonas B. Effects of Photodynamic action on E. coli. Arch Biochem Biophys. 1969;132:157–164
  100. Savino A, Angeli G. Photodynamic inactivation of E. coli by immobilized or coated dyes on insoluble supports. Water Res. 1985;19:1465–1469
  101. Menezes S, Capella MAM, Caldas LR. Photodynamic action of methylene blue; repair and mutation in Escherichia coli. J Photochem Photobiol B: Biol. 1990;5:505–517
  102. Tuveson RW, Larson RA, Kagan J. Role of cloned carotenoid genes experessed in Escherichia coli in protecting against inactivation by near-UV and specific phototoxic molecules. J Bacteriol. 1988;170:4675–4680
  103. Martin JP, Logsdon N. Oxygen Radicals are generated by dye-mediated intracellular photo-oxidations: a role for superoxide in photodynamic effects. Arch Biochem Biophys. 1987;256:39–49
  104. Koch WH, Bass GE. Sodium azide affects methylene blue concentration in Salmonella typhimurium and Saccharomyces cerevisae. Photochem Photobiol. 1984;39:841–845
  105. Gutter B, Speck WT, Rosenkranz HS. A study of the photoinduced mutagenicity of methylene blue. Mut Res. 1977;44:177–181
  106. Calzavara-Pinton PG, Venturini M, Sala R. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol B: Biol. 2005;78:1–6
  107. Wilson M, Mia N. Sensitization of Candida albicans to killing by low-power laser light. J Oral Pathol Med. 1993;22(8):354–357
  108. Propst C, Lubin L. In-vitro and in-vivo photosensitized inactivation of dermatophyte fungi by heterotricyclic dyes. Infect Immun. 1978;20:136–141
  109. Ouf SA, Abdel-Kader MH, Shokeir HA, El-Adly AA. Study of solar photosensitization processes on dermatophytic fungi. Acta Microbiol Pol. 2003;52:65–79
  110. Teichert MC, Jones JW, Usacheva MN, Biel MA. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(2):155–160
  111. Hamblin MR, Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease?. Photochem Photobiol Sci. 2004;3:436–450
  112. Bellin JS, Mohos SC, Oster G. Dye-sensitized photoinactivation of tumor cells in vitro. Cancer Res. 1961;21:1365–1371
  113. Bellin JS. Immunological properties of photodynamically inactivated tumor cells. Nature. 1962;194:851–852
  114. Gill WB, Huffman JL, Lyon ES, Bagley DH, Schoenberg HW, Straus FH. Selective surface staining of bladder tumors by intravesical methylene blue with enhanced endoscopic identification. Cancer. 1984;53:2724–2727
  115. Gill WB, Strauss FH. In vivo mapping of bladder cancer (chromocytoscopy for in vivo detection of neoplatic urothelial surfaces). Urology. 1984;23(Suppl.):63–66
  116. Wainwright M. Non-porphyrin photosensitizers in biomedicine. Chem Soc Rev. 1996;351–359
  117. Rueck AC, Akguen N, Heckelsmiller K, Kunzi-Rapp K, Beck G, Steiner RW. Nonlinear intracellular dynamics of photosensitizers during PDT. Proc SPIE. 1996;2929:47–50
  118. Wang CE, Schroeter AL, Su WPD. Acquired immunodeficiency syndrome-related Kaposi's sarcoma. Mayo Clin Proc. 1995;70:869–879
  119. Levine AM, Tulpule A. Clinical aspects and management of AIDS-related Kaposi's sarcoma. Eur J Cancer. 2001;37:1288–1295
  120. Evans LM, Itri LM, Campion M, et al. Interferon alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Immunother. 1991;10:39–50
  121. Real FX, Oettgen HF, Krown SE. Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon. J Clin Oncol. 1986;4:544
  122. Bernstein ZP, Wilson BD, Oseroff AR, et al. Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma. AIDS. 1999;13:1697–1704
  123. Tardivo JP, Del Giglio A, Paschoal LH, Baptista MS. Photodynamic therapy with phenothiazine compounds to treat an AIDS-related Kaposi's sarcoma. J Clin Oncol (submitted for publication).
  124. Rice L, Wainwright M, Phoemix DA. Phenothiazine photosensitizers III. Activity of methylene blue derivates against pigmented melanoma cell lines. J Chemother. 2000;12:94–104
  125. Lim DS, Ko SH, Lee WY. Silkworm-pheophorbide a mediated photodynamic therapy against B16F10 pigmented melanoma. J Photochem Photobiol B. 2004;74:1–6
  126. Baran R, Gupta AK, Pierard GE. Pharmacotherapy of onychomycosis. Expert Opin Pharmacother. 2005;6:609–624
  127. Kamp H, Tietz HJ, Lutz M, et al. Antifungal effect of 5-aminolevulinic acid PDT in Trichophyton rubrum. Mycoses. 2005;48:101–107

PII: S1572-1000(05)00097-9

doi: 10.1016/S1572-1000(05)00097-9

Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 3 , Pages 175-191 , September 2005

Article Tools

* Image Usage & Resolution